by Alicen Baran | Jul 21, 2021 | News
PLEASANT PRAIRIE, Wis.–(BUSINESS WIRE)–On Friday, July 16, 2021, Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, celebrated the opening of Project Tomorrow—the company’s new, state-of-the-art...
by Alicen Baran | Jun 22, 2021 | News
Milwaukee, June 21, 2021 – The Medical College of Wisconsin (MCW) School of Pharmacy partnered with Nexus Pharmaceuticals, Inc. for a pharmaceutical clinical-use study to compare the use of EMERPHED™, a ready-to-use (RTU) ephedrine sulfate product, to the...
by Alicen Baran | May 24, 2021 | News
KENOSHA, Wis. — Parkside Athletics and Nexus Pharmaceuticals are thrilled to announce a multi-year partnership in support of RangerVision 2020, Director of Athletics Andrew Gavin announced today. The partnership is highlighted by the creation of The Nexus...
by Alicen Baran | May 13, 2021 | News
LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Nexus Pharmaceuticals announced the launch of Succinylcholine Chloride Injection, USP in 200mg/10mL Multiple-Dose Vials. It is an AP-rated generic to QUELICIN™¥. “The launch of Succinylcholine Chloride represents Nexus...
by Deana Mndrucic | Mar 28, 2021 | News, Product Approvals
LINCOLNSHIRE, Ill.–Nexus Pharmaceuticals announced today that it has received U.S. Food and Drug Administration (FDA) approval for Potassium Chloride in Water for Injection in 10mEq/100mL, 10mEq/50mL, 20mEq/100mL, 40mEq/100mL and 20mEq/50mL Single-Dose IV bags....
by Deana Mndrucic | Mar 23, 2021 | News
LINCOLNSHIRE, Ill.–Nexus Pharmaceuticals, Inc. is pleased to announce that it has received authorization to occupy its new pharmaceutical manufacturing facility from the Village of Pleasant Prairie, Wisconsin. Nexus Pharmaceuticals, which specializes in...
